Filed: 2/14/2023ACC: 0001398344-23-003141
📋 What this filing means
DC FUNDS, LP filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $3.69M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$3.69M
Total AUM (reported)
1.86M
Total Shares
Allocation by class
COM$2.18M59.1%
ADS$1.51M40.9%
Portfolio Concentration
Top 3$3.69M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 1.86M
Sole
Full voting authority
1.86M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
VACCITECH PLC
SOLEShares642.20K
TypeSH
Market value$1.51M
40.86%
Sole
642.20K
Shared
0.00
None
0.00
WEREWOLF THERAPEUTICS INC
SOLEShares589.10K
TypeSH
Market value$1.21M
32.70%
Sole
589.10K
Shared
0.00
None
0.00
TSCAN THERAPEUTICS INC
SOLEShares630K
TypeSH
Market value$976.5K
26.44%
Sole
630K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VACCITECH PLCSOLE | ADS | 642.20K | SH | $1.51M 40.86% | 642.20K | 0.00 | 0.00 |
WEREWOLF THERAPEUTICS INCSOLE | COM | 589.10K | SH | $1.21M 32.70% | 589.10K | 0.00 | 0.00 |
TSCAN THERAPEUTICS INCSOLE | COM | 630K | SH | $976.5K 26.44% | 630K | 0.00 | 0.00 |